Lenvatinib 10mg Tab (30 tablets per pack) is a targeted cancer therapy medication used to treat certain types of cancer. As a tyrosine kinase inhibitor, it disrupts the growth of cancer cells by blocking specific proteins involved in tumor growth and blood vessel formation. It is commonly prescribed for conditions like thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma.

Key Features:

• Active Ingredient: Lenvatinib 10mg, a potent tyrosine kinase inhibitor.
• Presentation: Available as 30 tablets in a tamper-proof pack.
• Targeted Therapy: Specifically designed to block pathways that promote tumor growth.
• Applications: Effective for thyroid cancer, renal cell carcinoma, and liver cancer.
• Oral Administration: Easy-to-use tablet form for patient convenience.
• High Efficacy: Clinically proven to slow disease progression and improve outcomes.

Details and Benefits:

• Mechanism of Action: Works by inhibiting tyrosine kinase enzymes, thereby reducing cancer cell proliferation and angiogenesis (formation of blood vessels in tumors).
• Dosage: Typically prescribed as one tablet per day or as advised by a healthcare professional.
• Indications:
  • Differentiated thyroid cancer (DTC) refractory to radioactive iodine treatment.
  • Advanced renal cell carcinoma (RCC) in combination with other therapies.
  • Unrespectable hepatocellular carcinoma (HCC).
• Patient Benefits: Helps control tumor growth, reduces symptoms, and improves quality of life.
• Storage Instructions: Store in a cool, dry place at room temperature and out of reach of children.
• Precautions:
  • Not suitable for patients with known hypersensitivity to Lenvatinib.
  • Regular monitoring of blood pressure and liver function is required.
  • Use with caution in patients with cardiovascular issues or a history of bleeding disorders.